140 related articles for article (PubMed ID: 9488309)
1. Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function.
Dorigo O; Turla ST; Lebedeva S; Gjerset RA
J Neurosurg; 1998 Mar; 88(3):535-40. PubMed ID: 9488309
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazole.
Khalid MH; Tokunaga Y; Caputy AJ; Walters E
J Neurosurg; 2005 Jul; 103(1):79-86. PubMed ID: 16121977
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
4. Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor.
Nagane M; Narita Y; Mishima K; Levitzki A; Burgess AW; Cavenee WK; Huang HJ
J Neurosurg; 2001 Sep; 95(3):472-9. PubMed ID: 11565870
[TBL] [Abstract][Full Text] [Related]
5. Effects of clotrimazole on the growth, morphological characteristics, and cisplatin sensitivity of human glioblastoma cells in vitro.
Khalid MH; Shibata S; Hiura T
J Neurosurg; 1999 May; 90(5):918-27. PubMed ID: 10223459
[TBL] [Abstract][Full Text] [Related]
6. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction.
Broaddus WC; Liu Y; Steele LL; Gillies GT; Lin PS; Loudon WG; Valerie K; Schmidt-Ullrich RK; Fillmore HL
J Neurosurg; 1999 Dec; 91(6):997-1004. PubMed ID: 10584846
[TBL] [Abstract][Full Text] [Related]
7. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.
Kigawa J; Sato S; Shimada M; Kanamori Y; Itamochi H; Terakawa N
Gynecol Oncol; 2002 Feb; 84(2):210-5. PubMed ID: 11812076
[TBL] [Abstract][Full Text] [Related]
8. Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent.
Ogawa N; Fujiwara T; Kagawa S; Nishizaki M; Morimoto Y; Tanida T; Hizuta A; Yasuda T; Roth JA; Tanaka N
Int J Cancer; 1997 Nov; 73(3):367-70. PubMed ID: 9359484
[TBL] [Abstract][Full Text] [Related]
9. Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53.
Gjerset RA; Turla ST; Sobol RE; Scalise JJ; Mercola D; Collins H; Hopkins PJ
Mol Carcinog; 1995 Dec; 14(4):275-85. PubMed ID: 8519417
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the p53 gene and its expression in human glioblastoma cells.
Van Meir EG; Kikuchi T; Tada M; Li H; Diserens AC; Wojcik BE; Huang HJ; Friedmann T; de Tribolet N; Cavenee WK
Cancer Res; 1994 Feb; 54(3):649-52. PubMed ID: 8306326
[TBL] [Abstract][Full Text] [Related]
11. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.
Heise C; Lemmon M; Kirn D
Clin Cancer Res; 2000 Dec; 6(12):4908-14. PubMed ID: 11156251
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo.
Köck H; Harris MP; Anderson SC; Machemer T; Hancock W; Sutjipto S; Wills KN; Gregory RJ; Shepard HM; Westphal M; Maneval DC
Int J Cancer; 1996 Sep; 67(6):808-15. PubMed ID: 8824552
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer.
Miyake H; Hara I; Gohji K; Yamanaka K; Arakawa S; Kamidono S
Anticancer Res; 1998; 18(4C):3087-92. PubMed ID: 9713515
[TBL] [Abstract][Full Text] [Related]
14. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
Song K; Li Z; Seth P; Cowan KH; Sinha BK
Oncol Res; 1997; 9(11-12):603-9. PubMed ID: 9563008
[TBL] [Abstract][Full Text] [Related]
16. Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model.
Miyake H; Hara I; Hara S; Arakawa S; Kamidono S
Urology; 2000 Aug; 56(2):332-6. PubMed ID: 10925118
[TBL] [Abstract][Full Text] [Related]
17. Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism.
Riva CM
Anticancer Res; 2000; 20(6B):4463-71. PubMed ID: 11205289
[TBL] [Abstract][Full Text] [Related]
18. The effects of wild-type p53 gene transfection on the growth and chemotherapeutic sensitivity of human glioma cells.
Xiang W; Zhu X; Zhao H
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(1):44-6. PubMed ID: 12658781
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract][Full Text] [Related]
20. [Effects of wild-type p53 gene transfection on the growth and cisplatin sensitivity of cervical cancer cell line HeLa].
Wang X; Peng Z; Wang H
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):40-2. PubMed ID: 12599424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]